John Haanen
Theme leader Immunotherapy
Immunotherapy has transformed cancer treatment over the past decade, and the NKI has been at the forefront from the start. By integrating fundamental, translational and clinical research, we study how the immune system interacts with cancer and how this response can be strengthened. Our researchers investigate therapeutic options of myeloid immune cells modulation, explore immunotherapy in earlier disease stages, develop advanced cellular therapies, and investigate why some tumors remain resistant. The ultimate goal is clear: to make personalized immunotherapy effective for many more patients.
In the past decade, immunotherapy has given a new lease of life to part of our patients. Our research is aimed at developing immunotherapy for the majority of cancer patients.
John Haanen
Theme leader Immunotherapy
Accept cookies to play the video
This website uses cookies to ensure you get the best experience on our website.